The largest database of trusted experimental protocols

11 protocols using anti b220 apc

1

Immunophenotyping of Leukemic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bone marrow and spleen cells were collected from leukemic mice. Red blood cells (RBC) were lysed with NH4Cl RBC lysis buffer for 5 min at room temperature. The nucleated cells were then washed with cold PBS and stained with anti-Gr1-APC (1:20 dilution; cat. no. 553129; BD Biosciences), anti-CD3-PE (1:20 dilution; cat. no. 561824; BD Biosciences) and anti-CD19-PerCP-CyTM5.5 (1:20 dilution; cat. no. 551001; BD Biosciences) for cell lineages, and incubated with anti-CD43-PE (1:20 dilution; cat. no. 553271; BD Biosciences) and anti-B220-APC (1:20 dilution; cat. no. 553092; BD Biosciences) antibodies for B-cell development. The cells were incubated with the antibodies for 20 min at 4°C. Analysis was performed using CytoFLEX flow cytometer and the data were analyzed with CytExpert 2.1 (Beckman Coulter, lnc.).
+ Open protocol
+ Expand
2

Multicolor Flow Cytometry of Murine Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes obtained from control or treated tumor bearing mice were liquid-nitrogen frozen and thawed before tests. Then, for lymphoid cell analysis, they were stained in a one-step test with the following fluorophore-labeled anti-mouse monoclonal antibodies (mAbs): anti-CD4-APC (BD Pharmingen, USA, RM4-5), anti-CD8-PE-Cy7 (BD Pharmingen, USA, 53–6.7), anti-CD49b-PE (BD Pharmingen, USA, DX5) and anti-CD19-FITC (BD Pharmingen, USA, 1D3). Phenotype analysis was carried out using the Becton Dickinson FACSCalibur apparatus with Cell Quest Software. For myeloid cell characteristics, the flow cytometry analysis of MDSC surface phenotype was performed as described previously [16 (link)] using fluorophore-labeled anti-mouse mAbs: anti-CD11b-PerCP-Cy5.5 (BD Pharmingen, USA, M1/70), anti-B220-APC (BD Pharmingen, USA, RA3-6B2), anti-Ly6G-APC-Cy7 (BD Pharmingen, USA, 1A8), anti-Ly6C-PE (BD Pharmingen, USA, AL-21) and anti-MHCII-FITC (BD Pharmingen, USA, 25-9-17). The cells were stained for 45 min at 4°C. The viability of spleen cells was assessed by incubation with DAPI dye. The analysis was carried out using Becton Dickinson FACSFortessa apparatus with FACSDiva software.
+ Open protocol
+ Expand
3

Spleen Cell Fractionation and Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleen cells were stained with anti-CD45-FITC (BD Bioscience, Franklin Lakes, USA), anti-sca1-BV421 (BD Bioscience, Franklin Lakes, USA), anti-flk1-PE-Cy7 (BD Bioscience, Franklin Lakes, USA), anti-B220-APC (BD Bioscience, Franklin Lakes, USA), anti-IgM-Per-CP/Cy5.5 (BD Bioscience, Franklin Lakes, USA), anti-CD11b-APC/Cy7 (BD Bioscience, Franklin Lakes, USA) and anti-CD5-PE (BD Bioscience, Franklin Lakes, USA). Dead cells were identified by using a Zombie Aqua™ Fixable Viability Kit (Biolegend, San Diego USA) and doublets were excluded.
The following fractions were sorted by using flow cytometry (FACSAria, BD): CD45+, sca1+/flk1+ (sca1+/flk1+ cells); CD45+, B220+/IgM+, CD11b/CD5 (B2 cells); CD45+/sca1/flk1, B220+/IgM+, CD11b/CD5 (sca1/flk1 B2 cells).
+ Open protocol
+ Expand
4

Isolation and Analysis of Murine Blood, Spleen, and Lung Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
20 μl of peripheral blood were collected from the tail vein and collected in FACS buffer. Splenocytes were prepared by grinding spleens between frosted-end microscopic slides in petri dishes containing RPMI medium supplemented with 5% FCS. For analysis of pulmonary cells, mouse lungs were perfused through the pulmonary artery with 5 ml PBS. The lungs were excised, cut into small pieces and incubated for 60 min at 37°C in RPMI medium supplemented with 5% FCS and 200 μg/ml Collagenase D (Roche Diagnostics, Risch, Switzerland) and 10 μg/ml DNAse I (Sigma, Deisenhofen, Germany). The suspension was resuspended with a Pasteur pipette every 15 min. The reaction was stopped by 5 min incubation at 37°C with 5 mM EDTA. Lung cells were then mechanically separated in 100 μm mesh sized cell strainers.
Erythrocytes were lysed with Tris-buffered 0.15 M ammonium chloride for 1 min (lung) or 7 min (blood, spleen). Unspecific binding sites were blocked with anti-FcγR at 4°C for 10 min. The cells were extracellularly stained with anti-CD4-FITC, anti-CD4-APC, anti-B220-APC, anti-CD3-PE, anti-CD8-PerCP-Cy5.5, or anti-CD62L-FITC (all from BD, Heidelberg, Germany), respectively, for 1 h at 4°C. Cells were analyzed on an Accuri C6 cytometer or fixed in 1% PFA for 30 min and analyzed on an LSR-II cytometer (both BD). Absolute cell numbers of blood cell populations were measured with the C6 cytometer.
+ Open protocol
+ Expand
5

Multiparametric Flow Cytometry of Tumor Microenvironment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleen and tumor cells obtained from control or treated tumor-bearing mice were thawed, centrifuged, and incubated with monoclonal antibodies conjugated with fluorophores: anti-CD45 V500, anti-CD11b PerCP-Cy5.5, anti-CD11c BV605, anti-CD4 APC, anti-B220 APC, anti-CD49b APC, anti-Ly6C PE, anti-Ly6G APC-Cy7, anti-MHCII FITC, and anti-CD86 PE-Cy7 (all from BD Biosciences). After incubation, cells were suspended in PBS with DAPI dye (Molecular Probes) and analyzed using LSR Fortessa with Diva Software (Becton Dickinson) according to the procedure described by Rossowska and coworkers (27 (link)).
+ Open protocol
+ Expand
6

Flow Cytometric Analysis of Immune Cell Populations

Check if the same lab product or an alternative is used in the 5 most similar protocols
For analysis of cellular compositions in thymus, peripheral lymph nodes and spleen in March2−/− and March3−/− mice, the tissues were collected and single-cell suspensions were prepared. After depletion of red blood cells by ammonium-chloride-potassium (ACK) lysing buffer, cells were subjected to stain with the indicated antibodies for 30 min followed by flow cytometry analysis.
For analysis of myeloid cell expansion following Il-3 and Il-34 stimulation, cells were subjected to stain with the indicated antibodies for 30 min and analyzed by flow cytometry.
The following antibodies were used for flow cytometric analyses: anti-CD115-APC (eBioscience, 17-1152-82); anti-CD11b-FITC (BioLegend, 101206); anti-F4/80-PE (eBioscience, 12-4801-82); anti-CD3-FITC (BD Biosciences, 561798); anti-CD4-PE (BD Biosciences, 553048); anti-CD4-APC (BD Biosciences, 553051); anti-CD8-PB (BD Biosciences, 558106); anti-B220-APC (BD Biosciences, 553092); anti-F4/80-APC (BioLegend, 123115); anti-Ly6C-PE/Cy7 (BioLegend, 128017). Data were acquired on a Fortessa™ X-20 (BD Biosciences) and analyzed with FlowJo software.
+ Open protocol
+ Expand
7

Comprehensive Immunophenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry analysis was performed as previously described [28 (link), 30 (link)]. Samples were measured on a FACSCalibur or FACSCanto II (BD Bioscience, Franklin Lakes, USA) and analyzed with FlowJo (Tree Star, Ashland, USA). Dead cells were identified by using a Zombie Aqua™ Fixable Viability Kit (Biolegend, San Diego USA). Doublets were excluded in every analysis. Samples were stained with anti-sca1-APC (R&D Systems, Minneapolis, USA) anti-flk-1-PE (BD Bioscience, Franklin Lakes, USA), anti-B220-APC (BD Bioscience, Franklin Lakes, USA), anti-IgM-Per-CP/Cy5.5 (BD Bioscience, Franklin Lakes, USA), anti-CD11b-APC/Cy7 (BD Bioscience, Franklin Lakes, USA), anti-CD5-PE (BD Bioscience, Franklin Lakes, USA), anti-sca1-FITC (BD Bioscience, Franklin Lakes, USA), anti-flk1-PE-Cy7 (BD Bioscience, Franklin Lakes, USA), anti-CD3-FITC (BD Bioscience, Franklin Lakes, USA), anti-CD4-PE/Cy7 (eBioscience, Waltham, USA), anti-CD8-APC (Biolegend, San Diego, USA), anti-sca1-PerCP/Cy5.5 (eBioscience, Waltham, USA), anti-CD11b-PE (BD Bioscience, Franklin Lakes, USA), anti-CD115-APC (Biolegend, San Diego USA), anti-Gr1-FITC (BD Bioscience, Franklin Lakes, USA) and anti-CD45 FITC (BD Bioscience, Franklin Lakes, USA).
+ Open protocol
+ Expand
8

Mouse Spleen Cell Isolation and BrdU Incorporation Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mononuclear cells from mouse spleens or other organs were extracted using a cell strainer and stained with anti-B220–APC and anti-CD3–PE (BD). Propidium iodide was used to gate out dead cells. Results were acquired using an LSR I flow cytometer (BD) and analyzed in FlowJo software (Tree Star).
For BrdU incorporation analysis, CH12F3 cells (2 × 105/ml) were incubated for 30 min in culture medium containing 10 µM BrdU. Then, cells were harvested, washed twice with PBS, and fixed in cold 70% ethanol ON at 4°C. After removal of ethanol, DNA was denatured with 2 N HCl/0.5% Triton X-100 for 30 min at room temperature, neutralized with two washes of 0.1 M sodium tetraborate, pH 9, and resuspended in 70% ethanol. Cells were recovered by centrifugation, washed once with PBS, resuspended in 100 µl of blocking buffer (0.5% Tween 20 and 1% BSA in PBS) containing 10 µl mouse anti-BrdU antibody (BD), and incubated at room temperature for 30 min. After a wash with PBS, cells were incubated for 15 min at room temperature with goat anti–mouse Alexa Fluor 647 antibody diluted in blocking buffer. Finally, cells were washed with PBS once, resuspended in PBS containing 5 µg/ml propidium iodide, and analyzed using an Accuri flow cytometer.
+ Open protocol
+ Expand
9

Peptide-based CD8+ T cell assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNEU420–429 (PDSLRDLSVF) and the negative control peptide LCMV NP118–126 (RPQASGVYM) were produced in the Johns Hopkins Biosynthesis and Sequence Facility at a purity >95%. Antibodies used for flow cytometry studies were: anti-CD8-FITC (BD Biosciences), anti-CD8-PE (BD Biosciences), anti-CD8-PErCP (BD Biosciences), anti-CD8-APC (BD Biosciences), anti-galectin-3-AF647 (Biolegend), anti-galectin-3-PE (R&D), anti-PD1-PE (eBioscience), anti-LAG-3-PE (eBioscience), anti-Thy1.2-PerCP (Biolegend), anti-CD44-Pacific Blue (eBioscience), anti-CD11b-PE (BD Biosciences), anti-CD11c-FITC (BD Biosciences), anti-B220-APC (BD Biosciences), anti-Ly6C-PerCP-Cy5.5 (eBioscience), anti-IFNγ–PE (BD Biosciences), anti-IFNγ-Pacific Blue (eBioscience), and anti-Granzyme B-APC (BD Biosciences). Cellular division was assessed by labeling of high-avidity neu-specific CD8+ T cells with 1.5 μM CellTrace CFSE cell proliferation kit (Invitrogen) prior to adoptive transfer (8 (link)). Permeability was assessed with LIVE/DEAD Fixable Aqua Dead Cell Stain (Invitrogen). Antibody staining was conducted at 4°C for 20 minutes in FACS buffer (PBS, 5%FBS, 0.02% NaAzide).
+ Open protocol
+ Expand
10

Flow Cytometric Analysis of Intestinal Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For flow cytometric analysis, isolated intestinal ECs were stained with UEA-1-TRITC, anti-CD45–Pacific blue (PB; Biolegend, San Diego, CA), and Viaprobe (BD Biosciences, East Rutherford, NJ). Viaprobe CD45 UEA-1+ cells were identified as F-ECs. After blocking with anti-CD16/32 (FcγRII/III) (BD Biosciences), the following antibodies were used to stain spleen and LP cells: anti-CD45–PB (Biolegend), anti-CD11b–phycoerythrin (PE), anti-Foxp3-fluorescein isothiocyanate (FITC) (eBioscience, San Diego, CA), anti-CD11c–allophycocyanin (APC), anti-CD11b–FITC, anti-Gr-1-Alexa647, anti-CD3-APC, anti-B220-PE, anti-B220-APC, anti-IgA-FITC, anti-CD4-eFluor450, anti-CD90.2–FITC, anti-IL-17-PE, and anti-IFNγ-FITC (all from BD Biosciences), and Viaprobe. CD11b CD11c CD19 LP cells were purified by using anti-CD11b, anti-CD11c, and anti-CD19 MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany). The results were obtained by using a FACSAria cell sorter (BD Biosciences) with FlowJo software (TreeStar, Ashland, Oregon).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!